ECSP993130A - METHODS AND COMPOSITIONS FOR TREATING SINUSITIS, OTITIS MEDIA AND OTHER RELATED DISORDERS USING CORTICOSTEROIDS (CASE ALO916) - Google Patents

METHODS AND COMPOSITIONS FOR TREATING SINUSITIS, OTITIS MEDIA AND OTHER RELATED DISORDERS USING CORTICOSTEROIDS (CASE ALO916)

Info

Publication number
ECSP993130A
ECSP993130A ECSP993130A ECSP993130A EC SP993130 A ECSP993130 A EC SP993130A EC SP993130 A ECSP993130 A EC SP993130A EC SP993130 A ECSP993130 A EC SP993130A
Authority
EC
Ecuador
Prior art keywords
methods
compositions
corticosteroids
otitis media
alo916
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Nancy R Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP993130 priority Critical patent/ECSP993130A/en
Publication of ECSP993130A publication Critical patent/ECSP993130A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención describe composiciones que excluyen antibióticos y métodos para tratar sinusitis y/o otitis media no infecciosas. Las composiciones comprenden una cantidad terapéuticamente eficaz de un corticosteroide y los métodos comprenden administrar una composición farmacéutica que comprende una cantidad terapéuticamente eficaz de un coticosteroide, Los corticosteroides preferidos son furoato de mometasona.The present invention describes compositions that exclude antibiotics and methods of treating non-infectious sinusitis and / or otitis media. The compositions comprise a therapeutically effective amount of a corticosteroid and the methods comprise administering a pharmaceutical composition comprising a therapeutically effective amount of a coticosteroid. Preferred corticosteroids are mometasone furoate.

ECSP993130 1999-09-09 1999-09-09 METHODS AND COMPOSITIONS FOR TREATING SINUSITIS, OTITIS MEDIA AND OTHER RELATED DISORDERS USING CORTICOSTEROIDS (CASE ALO916) ECSP993130A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP993130 ECSP993130A (en) 1999-09-09 1999-09-09 METHODS AND COMPOSITIONS FOR TREATING SINUSITIS, OTITIS MEDIA AND OTHER RELATED DISORDERS USING CORTICOSTEROIDS (CASE ALO916)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP993130 ECSP993130A (en) 1999-09-09 1999-09-09 METHODS AND COMPOSITIONS FOR TREATING SINUSITIS, OTITIS MEDIA AND OTHER RELATED DISORDERS USING CORTICOSTEROIDS (CASE ALO916)

Publications (1)

Publication Number Publication Date
ECSP993130A true ECSP993130A (en) 2000-05-08

Family

ID=42044118

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP993130 ECSP993130A (en) 1999-09-09 1999-09-09 METHODS AND COMPOSITIONS FOR TREATING SINUSITIS, OTITIS MEDIA AND OTHER RELATED DISORDERS USING CORTICOSTEROIDS (CASE ALO916)

Country Status (1)

Country Link
EC (1) ECSP993130A (en)

Similar Documents

Publication Publication Date Title
CY1111726T1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ASTHMA
BR9812753A (en) Pharmaceutical combination, use thereof, process for treating an inflammatory disease, and pharmaceutical composition
WO2003072195A3 (en) Method for administering glp-1 molecules
SV1998000029A (en) PIRAZINE COMPOUNDS REF. PG3186
PT1586322E (en) COMPOSITIONS FOR COMPOSITION OF TALIDOMIDE AND DEXAMETHASONE FOR CANCER TREATMENT
PT2336184E (en) ADMINISTRATION OF AGENTS FOR THE TREATMENT OF INFLAMMATION
GT200500007A (en) [1,8] NAFTIRIDIN-2-WAVES AND RELATED COMPOUNDS FOR THE TREATMENT OF CHICHOPHRENIA.
IL162214A0 (en) Pyridine derivatives and pharmaceutical compositions containing the same
CY1108676T1 (en) Ophthalmic suspension comprising an ophthalmic drug, a poloxamine AND AN AGENT REGULATION OF TONIKOTITAS TYPE GLYKOLIS, USE OF SAID COMPOSITION FOR THE PRODUCTION OF A medicament for treating ophthalmic disorders
ECSP034518A (en) NEW RETINOIDS FOR THE EMPHYSEMA TREATMENT
ECSP088635A (en) ORAL FORMULATIONS THAT INCLUDE TIGECICLINE
MX2022000646A (en) DERIVATIVES OF N-((1,2,3,5,6,7-HEXAHYDRO-S-INDACEN-4-IL)CARBAMOIL)-4,5,6,7- TETRAHYDROBENZOFURAN-2-SULFONAMIDE AND RELATED COMPOUNDS AS MODULATORS OF NLPR3 FOR THE TREATMENT OF MULTIPLE SCLEROSIS (MS).
CY1105225T1 (en) 5-B-SAPOGENIN AND PSEUDOSAPOGENIN DERIVATIVES AND THEIR USE IN THE TREATMENT OF DEMENTIA
DK0712311T3 (en) Antiglucocorticoid steroids for the treatment of anxiety disorders
DK0912185T3 (en) New pharmaceutical compositions containing steroid nitrate ester derivatives which can be used as anti-inflammatory drugs
DE69838882D1 (en) PHARMACEUTICALLY EFFECTIVE COMPOUNDS AND METHODS OF THEIR APPLICATION
NO304113B1 (en) Crystalline thiagabine hydrochloride monohydrate, pharmaceutical composition comprising it, and use thereof for the manufacture of a medicament
BRPI0411864A (en) combination of src kinase inhibitors and chemotherapeutic agents for the treatment of proliferative diseases
ES2188995T3 (en) USE OF AN INHIBITOR OF THE H +, K + -ATPASA IN THE TREATMENT OF NASAL POLYPS.
MXPA04001398A (en) Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine.
DE60311665D1 (en) PHARMACEUTICAL COMPOSITIONS
AR019947A1 (en) METHOD TO TREAT OR PREVENT DISORDERS CAUSED BY DYSFUNCTIONS OF THE INTESTINAL MOTILITY IN HUMAN BEINGS AND PHARMACEUTICAL COMPOSITIONS OF APPLYING SUCH METHOD
RU94041028A (en) Application of melatonin derivatives for treating desynchronization disorders, pharmaceutical composition
BRPI0408113A (en) methods for treating or preventing a central nervous system disorder, for controlling a central nervous system disorder and for reducing or preventing an adverse effect associated with the administration of a secondary active ingredient in a patient suffering from a central nervous system disorder, and pharmaceutical composition
PA8481701A1 (en) METHODS AND COMPOSITIONS FOR TREATING SINUSITIS, OTITIS MEDIA AND OTHER RELATED DISORDERS USING CORTICOSTEROIDS